ABANDONED - NO STATEMENT OF USE FILED
no statement of use filed
on 03 Jun 2024
Last Applicant/ Owned by
FOURTH FLOOR
BRISBANE
CA
94005
Serial Number
97164184 filed on 09th Dec 2021
Registration Number
N/A
Correspondent Address
Aaron D. Hendelman
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
LLDX
Custom design and development of chemical reagents and biochemical assays; research and product development services for others in the field of biotechnology; providing laboratory research services in the field of gene expression; genetic data mining; development of molecule identification methods for acquiring, analyzing, and managing biological and genetic information, in the fields of genetics Read More
Classification Information
Class [044]
Medical, Beauty & Agricultural Services
Medical diagnostic testing, monitoring and reporting services; genetic medical testing service; providing medical information to patients and medical professionals in the form of reports in a wide variety of medical fields; medical services; providing medical information relating to the diagnostic, prophylactic, and therapeutic properties of assays and reagents; providing medical record analysis services designed to provide patients and medical professionals with custom tailored information about the range of possible diagnoses and therapies
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [042]
Computer & Software Services & Scientific Services
Custom design and development of chemical reagents and biochemical assays; research and product development services for others in the field of biotechnology; providing laboratory research services in the field of gene expression; genetic data mining; development of molecule identification methods for acquiring, analyzing, and managing biological and genetic information, in the fields of genetics research and development services for others in the fields of diagnostic compounds for use in medicine, measuring apparatus for use in product research and development, laboratory separation and purification processes, laboratory testing processes, and industrial quality control processes; developing systems for acquiring, analyzing, and managing biological and genetic information in the fields of diagnostic reagents, forensics, medicine, and genetics; research, design, and development services for others in the fields of diagnostic reagents, compounds and devices, measuring apparatus for use in product research and development, laboratory separation and purification processes, laboratory testing processes, and industrial quality control processes; chemical screening analysis for others
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [010]
Medical Instrument Products
Diagnostic test kits for use in microbial testing comprising reagents, slides, solid matrix materials, microfluidic devices, and support documentation therefor
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [005]
Pharmaceutical Products
Gene therapy products, namely, living and genetically engineered tissues for use in predictive and diagnostic medical purposes; medical diagnostic reagents; medical diagnostic reagents and assays for testing and predicting patient recovery; medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection; diagnostic test kits for medical use comprising reagents, slides, solid matrix materials, microfluidic devices sold as a unit with instructional manuals therefor; medical diagnostic test kits for detecting pathogens, comprising reagents for medical use; medical diagnostic reagents for RNA transcription and microRNA expression profiling, proteomics, small molecule analysis, single nucleotide polymorphisms analysis, DNA sequencing, detection of polymorphisms in human fluids, detection of copy number variations, and clinical, oncology, and hematology diagnostics; medical diagnostic reagents and diagnostic reagents for clinical or medical laboratory use, diagnostic reagents for medical in vitro use in biochemistry, clinical chemistry and microbiology, RNA and microRNA expression transcription profiling, proteomics, clinical diagnostics, small-molecule analysis, single nucleotide polymorphisms analysis, and DNA sequencing; tests designed to isolate and extract cells for genetic analysis comprised of reagents for medical diagnostic use; medical diagnostic reagents and assays for testing of body fluids; kits consisting primarily of medical diagnostic reagents and assays for testing of body fluids; reagents in the form of cell markers and molecule markers for medical purposes
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [001]
Chemical Products
Assays and reagents for research purposes; diagnostic preparations for scientific use; diagnostic reagents for scientific research relating to molecular identification and digital quantification; chemical test kits for scientific research use comprising reagents, slides, solid matrix materials, microfluidic devices and support documentation therefor; chemical test kits comprising reagents for scientific research relating to molecular identification; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; diagnostic reagents for clinical or medical laboratory use, namely, reagents for proteomics, RNA transcription, and microRNA expression profiling, small-molecule analysis, single nucleotide polymorphisms analysis, DNA sequencing, detection of polymorphisms in human fluids, detection of copy number variations, and clinical, oncology, and hematology diagnostics; reagents for scientific or medical research use, diagnostic preparations and reagents for scientific or research uses, namely, RNA transcription profiling, proteomics, clinical diagnostics of samples containing microorganisms or human fluids, small-molecule analysis, single nucleotide polymorphisms analysis, and DNA sequencing; test kits consisting of chemical preparations for scientific research purposes for the detection, diagnosis, progress monitoring and progress prediction of diseases, namely inflammations, infections, disorders of the central nervous systems, cardiovascular, neurological, endocrine, autoimmune and genetic disorders and cancers; assays, reagents, enzymes, polymerases, buffers and nucleotides, and kits comprised thereof, all for scientific or research use; diagnostic reagents for scientific in vitro use in biochemistry, clinical chemistry and microbiology, RNA and microRNA expression transcription profiling, proteomics, clinical diagnostics, small-molecule analysis, single nucleotide polymorphisms analysis, and DNA sequencing
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 97164184
Mark Type
No Service Mark
Attorney Docket Number
No 53797-TM1005
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 12th Jul 2024 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| 03rd Jun 2024 | ABANDONMENT - NO USE STATEMENT FILED |
| 17th Apr 2024 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| 31st Oct 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 05th Sep 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 05th Sep 2023 | PUBLISHED FOR OPPOSITION |
| 16th Aug 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 28th Jul 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 27th Jul 2023 | ASSIGNED TO EXAMINER |
| 27th Jul 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |